Investor Login
Bay City Capital
  • Profile
  • Team
  • Portfolio
  • News & Events
  • Contact
  • Investor Login
Filters
Investing In Life Sciences
Founded in 1997
5 venture capital funds
$1.3 billion in capital commitments
Invested in over 100 companies worldwide
 

Investing In Life Sciences

Founded in 1997

5 venture capital funds

$1.3 billion in capital commitments

Invested in over 100 companies worldwide

 

Investing In Life Sciences
Founded in 1997
5 venture capital funds
$1.3 billion in capital commitments
Invested in over 100 companies worldwide
 

Investing In Life Sciences

Founded in 1997

5 venture capital funds

$1.3 billion in capital commitments

Invested in over 100 companies worldwide

 

Investing In Life Sciences
Founded in 1997
5 venture capital funds
$1.3 billion in capital commitments
Invested in over 100 companies worldwide
 

Investing In Life Sciences

Founded in 1997

5 venture capital funds

$1.3 billion in capital commitments

Invested in over 100 companies worldwide

 

Portfolio News

Dermira's Receives FDA Fast Track for Lebrikizuma... > Dermira's Receives FDA Fast Track for Lebrikizuma...

Portfolio

Synchronicity Announces Therapeutic Glioblastoma Treat... > Synchronicity Announces Therapeutic Glioblastoma Treat...

Joint Venture

Bay City Capital and GF Xinde Announce New Fund > Bay City Capital and GF Xinde Announce New Fund

Portfolio News

MGL-3196 Achieves Liver Biopsy Endpoints in NASH Patie... > MGL-3196 Achieves Liver Biopsy Endpoints in NASH Patie...

Company Formation

BCC & Partners Launch Bridge Medicines > BCC & Partners Launch Bridge Medicines

M&A

Accriva Acquired by Werfen > Accriva Acquired by Werfen

FDA Approval

Nevro Receives FDA Approval for Senza Spinal Cord Stim... > Nevro Receives FDA Approval for Senza Spinal Cord Stim...

M&A

Cydan Announces Acquisition of Vtesse, Inc. by Sucampo... > Cydan Announces Acquisition of Vtesse, Inc. by Sucampo...

© 2023 Bay City Capital LLC. All rights reserved.

Privacy policy

twitter